Ana is a molecular biologist with a passion for discovery and communication. As a science writer, she looks for connecting the public, in particular patients and healthcare providers, with clear and quality information about the latest medical advances. Ana holds a Ph.D. in Biomedical Sciences from the University of Lisbon, Portugal, where she specialized in infectious diseases, epigenetics, and gene expression.
Oxervate (cenegermin) eyedrops are effective and safe at promoting healing and reducing cornea lesions in patients with neurotrophic keratitis (NK), a clinical trial shows. The results were reported in the ... Read more
Oxervate (cenegermin) and Cacicol (RGTA) are currently the primary treatments for persistent and difficult-to-treat corneal ulcers caused by neurotrophic keratitis (NK), a review study reports. Oxervate is approved in both the ... Read more